BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15178638)

  • 1. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases.
    Mongillo M; McSorley T; Evellin S; Sood A; Lissandron V; Terrin A; Huston E; Hannawacker A; Lohse MJ; Pozzan T; Houslay MD; Zaccolo M
    Circ Res; 2004 Jul; 95(1):67-75. PubMed ID: 15178638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.
    Leroy J; Abi-Gerges A; Nikolaev VO; Richter W; Lechêne P; Mazet JL; Conti M; Fischmeister R; Vandecasteele G
    Circ Res; 2008 May; 102(9):1091-100. PubMed ID: 18369156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.
    Jurevicius J; Skeberdis VA; Fischmeister R
    J Physiol; 2003 Aug; 551(Pt 1):239-52. PubMed ID: 12815180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Adrenergic cAMP signals are predominantly regulated by phosphodiesterase type 4 in cultured adult rat aortic smooth muscle cells.
    Zhai K; Hubert F; Nicolas V; Ji G; Fischmeister R; Leblais V
    PLoS One; 2012; 7(10):e47826. PubMed ID: 23094097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of cardiac excitation-contraction coupling by cAMP phosphodiesterase subtypes.
    Mika D; Bobin P; Pomérance M; Lechêne P; Westenbroek RE; Catterall WA; Vandecasteele G; Leroy J; Fischmeister R
    Cardiovasc Res; 2013 Nov; 100(2):336-46. PubMed ID: 23933582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
    Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Zhou W; Grande JP
    Exp Biol Med (Maywood); 2006 Mar; 231(3):288-95. PubMed ID: 16514175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes.
    Kerfant BG; Zhao D; Lorenzen-Schmidt I; Wilson LS; Cai S; Chen SR; Maurice DH; Backx PH
    Circ Res; 2007 Aug; 101(4):400-8. PubMed ID: 17615371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective changes in cytosolic β-adrenergic cAMP signals and L-type Calcium Channel regulation by Phosphodiesterases during cardiac hypertrophy.
    Abi-Gerges A; Castro L; Leroy J; Domergue V; Fischmeister R; Vandecasteele G
    J Mol Cell Cardiol; 2021 Jan; 150():109-121. PubMed ID: 33184031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cyclic nucleotide phosphodiesterases in the cAMP compartmentation in cardiac cells].
    Mika D; Leroy J; Vandecasteele G; Fischmeister R
    Biol Aujourdhui; 2012; 206(1):11-24. PubMed ID: 22463992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
    Stehlik J; Movsesian MA
    Expert Opin Investig Drugs; 2006 Jul; 15(7):733-42. PubMed ID: 16787138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle.
    Vargas ML; Hernandez J; Kaumann AJ
    Br J Pharmacol; 2006 Jan; 147(2):158-63. PubMed ID: 16331293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure.
    Ding B; Abe JI; Wei H; Huang Q; Walsh RA; Molina CA; Zhao A; Sadoshima J; Blaxall BC; Berk BC; Yan C
    Circulation; 2005 May; 111(19):2469-2476. PubMed ID: 15867171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of phosphodiesterases in the shaping of sub-plasma-membrane cAMP oscillations and pulsatile insulin secretion.
    Tian G; Sågetorp J; Xu Y; Shuai H; Degerman E; Tengholm A
    J Cell Sci; 2012 Nov; 125(Pt 21):5084-95. PubMed ID: 22946044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergic PDE3 and PDE4 control intracellular cAMP and cardiac excitation-contraction coupling in a porcine model.
    Mika D; Bobin P; Lindner M; Boet A; Hodzic A; Lefebvre F; Lechène P; Sadoune M; Samuel JL; Algalarrondo V; Rucker-Martin C; Lambert V; Fischmeister R; Vandecasteele G; Leroy J
    J Mol Cell Cardiol; 2019 Aug; 133():57-66. PubMed ID: 31158360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.
    Adderley SP; Dufaux EA; Sridharan M; Bowles EA; Hanson MS; Stephenson AH; Ellsworth ML; Sprague RS
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1617-24. PubMed ID: 19252089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
    Ahmad F; Murata T; Shimizu K; Degerman E; Maurice D; Manganiello V
    Oral Dis; 2015 Jan; 21(1):e25-50. PubMed ID: 25056711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.